Measles Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

Measles Vaccine Trends and Forecast

The future of the global measles vaccine market looks promising with opportunities in the hospital, vaccination center, and community clinic markets. The global measles vaccine market is expected to grow with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are growing incidence of measles, expansion in immunization programs, and continuous development of new vaccines.

A more than 150-page report is developed to help in your business decisions.

Measles Vaccine by Segment

The study includes a forecast for the global measles vaccine by type, application, end use, and region.

Measles Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Mumps Measles Rubella Vaccine
• Live MMR-II

Measles Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Pediatric Population
• Adolescent Population
• Adult Population

Measles Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Vaccination Centers
• Community Clinics

Measles Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Measles Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies measles vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the measles vaccine companies profiled in this report include-

• China National Biotech
• Merck & Company
• Medimmune Health
• JC Green Cannabis
• Bavarian Nordic
• Sanofi
• Pfizer
• Novartis
• Johnsons & Johnsons
• Emergent Biosolutions

Measles Vaccine Market Insights

Lucintel forecasts that pediatric population is expected to witness highest growth over the forecast period due to rising use of the measles vaccination among these people owing to its increased efficacy.

North America is expected to witness highest growth over the forecast period.

Features of the Global Measles Vaccine Market

Market Size Estimates: Measles vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Measles vaccine market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Measles vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the measles vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the measles vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the measles vaccine market size?

Answer: The global measles vaccine market is expected to reach an estimated $xx billion by 2030.

Q.2 What is the growth forecast for measles vaccine market?

Answer: The global measles vaccine market is expected to grow with a CAGR of 5.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the measles vaccine market?

Answer: The major drivers for this market are growing incidence of measles, expansion in immunization programs, and continuous development of new vaccines.

Q4. What are the major segments for measles vaccine market?

Answer: The future of the measles vaccine market looks promising with opportunities in the hospital, vaccination center, and community clinic markets.

Q5. Who are the key measles vaccine market companies?

Answer: Some of the key measles vaccine companies are as follows:

• China National Biotech
• Merck & Company
• Medimmune Health
• JC Green Cannabis
• Bavarian Nordic
• Sanofi
• Pfizer
• Novartis
• Johnsons & Johnsons
• Emergent Biosolutions

Q6. Which measles vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that pediatric population is expected to witness highest growth over the forecast period due to rising use of the measles vaccination among these people owing to its increased efficacy.

Q7. In measles vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the measles vaccine market by type (mumps measles rubella vaccine and live mmr-II), application (pediatric population, adolescent population, and adult population), end use (hospitals, vaccination centers, and community clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?